A Study of Vegf Expression in Radiation Dermatitis
Overview
Tab Title Description
Study type
ObservationalDescribes the nature of a clinical study. Types include:
- Observational study — observes people and measures outcomes without affecting results.
- Interventional study (clinical trial) — studies new tests, treatments, drugs, surgical procedures or devices.
- Medical records research — uses historical information collected from medical records of large groups of people to study how diseases progress and which treatments and surgeries work best.
Study IDs
Site IRB
- Rochester, Minnesota: 16-001596
Sponsor Protocol Number: 16-001596
About this study
To determine if VEGF expression is induced in patients who experienced radiation dermatitis.
Participation eligibility
Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.
Inclusion Criteria:
- Any new patient enrolled in once daily external beam radiation for primary treatment of cancer
Exclusion Criteria
- Radiation in anatomically sensitive area for treatment such as perio-orbital, breast, rectal/perianal, perineal/scrotal, etc
- Currently undergoing chemotherapy in addition to radiation treatment
- Previous irradiation treatment in the same area
- Known collagen-vascular disorder or diabetes
- Currently treated with VEGF-targeting therapeutics
- Currently on anticoagulation therapy
- Previous history of delayed wound healing
- Younger than 18 years old
- Pregnant
- Unable to give consent
- Current or recent use of sirolimus ( < 3 months)
Participating Mayo Clinic locations
Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.
| Mayo Clinic Location |
Status |
|
Rochester, Minn.
Mayo Clinic principal investigator Stephen Ekker, Ph.D. |
Closed for enrollment |
|
More information
Publications
Publications are currently not available